Determination of Malondialdehyde (MDA) and Some Antioxidant Activities in Rheumatoid arthritis Patients

Authors

  • Elham Abdulqadir Abdulrahman1 1 Department of Pharmaceutical Chemistry, College of Medical and Applied Sciences, Charmo University, Chamchamal 46023, Iraq.
  • Halit Demir2 2 Van Yuzuncu Yil University, Faculty of Science, Department of Chemistry, Van, Turkey
  • Bakhtyar Kamal Aziz3 3 Department of Nano-Science and Applied Chemistry, College of Medicals and Applied Sciences, Charmo University, Cahmchamal 46023, Iraq

DOI:

https://doi.org/10.36329/jkcm/2023/v2.i10.12258

Keywords:

inflammation, rheumatoid arthritis

Abstract

Background: Muscle weakness is a common comorbidity of several severe diseases which results in a reduced independence and quality of life and for the afflicted patients. Patients with rheumatoid arthritis (RA), a disease characterized by a chronic inflammation of the joints, commonly report of muscle weakness as a complication. Muscle weakness is the result of reduced muscle size and intramuscular impairments (i.e., intrinsic muscle dysfunction).

Downloads

Download data is not yet available.

Downloads

Published

2023-11-05

How to Cite

Elham Abdulqadir Abdulrahman1, Halit Demir2, & Bakhtyar Kamal Aziz3. (2023). Determination of Malondialdehyde (MDA) and Some Antioxidant Activities in Rheumatoid arthritis Patients. Journal of Kufa for Chemical Sciences, 2(10), 122–136. https://doi.org/10.36329/jkcm/2023/v2.i10.12258